Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

RA Capital Management

Venture capital firm · Founded 2001 · Active in 2026

RA Capital Management is a venture capital firm based in USA, founded in 2001. The page below shows 92 Power Law outcomes from RA Capital Management's portfolio — 69 unicorns ($1B+ valuation) and 5 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).

Outcomes are concentrated in Biotech & Life Sciences · Health Tech & Medtech; top portfolio geographies are USA · UK · Canada. RA Capital ranks #176 in Global in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.

92 Power Law outcomes Power Law Ranking #176 · Global · 92 Power Law outcomes · Active 2026
Unicorns ↑ 82% 5y
69
Decacorns ↑ 200% 5y
3
Thoroughbreds ↑ 13% 5y
30
01 · Exits

RA Capital’s biggest exits.

RA Capital portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 2015
Entered Series B+Now $28.2B
IPO · 2015
Entered Series B+Now $15.6B
$7.5B IPO · 2018
Entered Series B+Now $14.7B
$457M IPO · 2019
Entered Series B+Now $12.6B
$630M IPO · 2020
Entered Series B+Now $12.0B
$163M IPO · 2017
Now $10.0B
IPO · 2004
Entered Series B+Now $9.8B
IPO · 2015
Entered Series B+Now $9.2B
IPO · 2015
Entered Series B+Now $8.2B
$1.3B IPO · 2020
Now $6.9B
$94M IPO · 2017
Entered Series B+Now $6.7B
IPO · 2016
Entered Series B+Now $6.2B
$5.9B IPO · 2020
Entered Series ANow $5.0B
IPO · 2016
Entered Series B+Now $5.8B
$130M IPO · 2016
Now $5.6B
$250M IPO · 2020
Entered Series B+Now $5.2B
$1.1B IPO · 2023
Entered Series B+Now $5.1B
$150M IPO · 2022
Now $5.0B
$4.9B IPO · 2025
Entered Series B+Now $4.9B
$1.2B IPO · 2024
Entered Series B+Now $4.6B
IPO · 2015
Entered Series B+Now $4.5B
IPO · 2023
Entered Series B+Now $3.6B
$326M IPO · 2022
Now $3.5B
IPO · 2014
Entered Series B+Now $3.3B
02 · Estimated holdings

RA Capital’s selected top holdings.

An estimate of RA Capital’s largest live positions — disclosed shareholding × Dealroom’s latest valuation — across 2 companies where RA Capital is a named shareholder, worth about $215M in estimated equity value.

#CompanyEst. stakeValuationEst. value
  1. 1 FreenomeHealth · Unicorn 8.5% $1.5B $128M
  2. 2 SomatusHealth · Unicorn 3.5% $2.5B $88M

Estimated value = RA Capital’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →

+38 more $1B+ exits on the full Dealroom profile.

03 · Portfolio analysis

The 92 RA Capital Power Law outcomes ($100M+ revenue or $1B+ valuation).

Snapshot of where the outcomes are concentrated by country, sector, and stage entered.

By countryCount
  1. USA78
  2. UK5
  3. Canada3
  4. Denmark2
  5. China2
  6. Netherlands1
  7. Belgium1
By sectorCount
  1. Biotech & Life Sciences90
  2. Health Tech & Medtech2
By stage enteredCount
  1. Series B+65
  2. Series A9
  3. Seed2
04 · Portfolio market map

RA Capital's 92 Power Law outcomes.

Stage entered
Outcome tier
Region
Group by
92 of 92 Power Law outcomes
05 · Power Law comparison

How does RA Capital stack up?

RA Capital in orange, your selection in blue and other colours. Pick from the global roster of 35 peer investors — scope by startup location or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of unicorns minted in the selected startup location — peaks reveal vintage years.

Compare against

Share of new unicorns per year

% of global unicorns minted that year, year by year · hover the chart to see which unicorns

Stage focus

Companies by entry stage and outcome tier

Sector focus

Companies per investor across the 10 highest-volume sectors
Source: Dealroom Power Law dataset. Investors shown are the 2026 Power Law top 35 by combined entry-to-outcome score, drawn from the overview and locations_data sheets. Funnel-matrix axes rescale per-axis using the maximum among the currently selected investors, so the polygons always fill the chart for shape comparison.
06 · Portfolio founders

Where RA Capital's portfolio founders come from — and where they studied.

105 founders across the 92 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. Harvard University and Aiolos Bio are the deepest single pipelines.

LocationCount
United States52
United Kingdom19
China7
India5
Singapore4
Israel1
View on app →
UniversityCount
Harvard University6
UCLA5
Aston University4
Pontifical Catholic University of Chile3
Harvard Medical School3
Keele University2
King's College London2
University of Wolverhampton2
University of Rochester2
MIT Sloan School of Management2
+39 more →
Origin companyCount
Aiolos Bio3
BioMarin Pharmaceutical2
EQRx2
Moderna Therapeutics2
Gyroscope Therapeutics2
Symphogen1
Arvinas1
Turnstone Biologics1
Forward Pharma1
Onyx Pharmaceuticals1
+28 more →
Origin = country a founder is born in or grew up in (founders may have multiple origins; counts include all entries). University = highest-listed degree. Origin company = a previous employer where the founder was tagged before starting their current company.

Market sentiment

What the market is saying about RA Capital Management

An AI-synthesized read of the highest-engagement posts about RA Capital on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

In the news

Latest news about RA Capital Management

Recent press, funding announcements, and portfolio moves mentioning RA Capital — pulled live from Dealroom's news feed.

See all news

Want the full picture on RA Capital Management?

The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.